Coya Therapeutics Inc expected to post a loss of 34 cents a share - Earnings Preview

Coya Therapeutics

07/08/2026 17:45

Coya Therapeutics Inc COYA.OQ COYA.O is expected to  show a fall in quarterly revenue when it reports  results on August 10 (estimated) for the period ending June 30 2026
The Houston Texas-based  company is expected to report a 39.0% decrease in revenue to $100 thousand from $164 thousand a year ago, according to the mean estimate from 5 analysts, based on LSEG data.
​LSEG's mean analyst estimate for Coya Therapeutics Inc is for a loss of 34 cents per share. 
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for Coya Therapeutics Inc is $16.00, about 249.3% above its last closing price of $4.58
Previous quarterly performance (using preferred earnings measure in US dollars). ​
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE 
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2026
-0.42
-0.41
-0.32
Beat
22.6
Dec. 31 2026
-0.13
-0.27
-0.34
Missed
-24.6
Sep. 30 2025
-0.19
-0.27
-0.13
Beat
52.4​
Jun. 30 2025
-0.45
-0.39
-0.36
Beat
8.4
​​Mar. 31 2025
-0.17
-0.19
-0.44
Missed
-125.6
Dec. 31 2024
-0.24
-0.26
-0.17
Beat
35.8​
Sep. 30 2024
-0.41
-0.41
-0.26
Beat
37.3
Jun. 30 2024
-0.14
-0.14
-0.19
Missed
-35.7
This summary was machine generated August 7 at 16:45 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)